Pulmonary infections complicating ARDS
Sign Up to like & getrecommendations! Published in 2020 at "Intensive Care Medicine"
DOI: 10.1007/s00134-020-06292-z
Abstract: Pulmonary infection is one of the main complications occurring in patients suffering from acute respiratory distress syndrome (ARDS). Besides traditional risk factors, dysregulation of lung immune defenses and microbiota may play an important role in… read more here.
Keywords: complicating ards; pulmonary infections; infection; infections complicating ... See more keywords
Differential diagnosis of pulmonary infections in immunocompromised patients using high-resolution computed tomography
Sign Up to like & getrecommendations! Published in 2019 at "European Radiology"
DOI: 10.1007/s00330-019-06235-3
Abstract: ObjectivesThe aims of this study were to compare the high-resolution computed tomography (HRCT) findings of pulmonary infections in immunocompromised patients and to assess the usefulness of HRCT in the differential diagnosis of these infections.MethodsA total… read more here.
Keywords: computed tomography; pulmonary infections; differential diagnosis; infections immunocompromised ... See more keywords
High resolution nanoscale probing of bacteriophages in inhalable dry powder formulation for pulmonary infections.
Sign Up to like & getrecommendations! Published in 2019 at "Analytical chemistry"
DOI: 10.1021/acs.analchem.9b02282
Abstract: Use of powder phage formulations for the treatment of multidrug resistant pulmonary infections is gaining attention. To achieve therapeutic benefits, it is critical for phages to remain stable in the formulation. Assessment of phage stability… read more here.
Keywords: pulmonary infections; phage; formulation; powder ... See more keywords
Extra-pulmonary applications of procalcitonin: an updated literature review
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Molecular Diagnostics"
DOI: 10.1080/14737159.2022.2094705
Abstract: ABSTRACT Introduction Procalcitonin (PCT) is a biomarker with established performance in the differentiation between bacterial and viral infections, predominantly in pulmonary infections, as well as the diagnosis and prognosis of bacterial sepsis. However, the role… read more here.
Keywords: pulmonary applications; meningitis; pct; pulmonary infections ... See more keywords
Evaluation of the Diagnostic Accuracy and Clinical Utility of Fungal Profile Plus Polymerase Chain Reaction Assay in Pulmonary Infections
Sign Up to like & getrecommendations! Published in 2022 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofac646
Abstract: Abstract Background Pulmonary infections due to Aspergillus, Mucorales, and Nocardia have high morbidity and mortality, in part due to diagnostic challenges. Commercially available molecular assays on bronchoalveolar lavage fluid (BALF) may have increased sensitivity over… read more here.
Keywords: sensitivity; chain reaction; polymerase chain; pulmonary infections ... See more keywords
Clofazimine for Rapidly Growing Mycobacterial Infections
Sign Up to like & getrecommendations! Published in 2017 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofx163.1798
Abstract: Abstract Background Rapidly growing mycobacteria (RGM) have high rates of antibiotic resistance and require prolonged therapy with considerable toxicity. Less toxic and more effective therapies are needed. One promising agent is clofazimine (CFZ), an antibiotic… read more here.
Keywords: pulmonary infections; treatment; infection; pulmonary infection ... See more keywords
Advancing bacteriophages as a treatment of antibiotic-resistant bacterial pulmonary infections
Sign Up to like & getrecommendations! Published in 2022 at "Current Opinion in Pulmonary Medicine"
DOI: 10.1097/mcp.0000000000000864
Abstract: Purpose of review The current article summarizes the recent advances in the use of bacteriophages to treat pulmonary infections, particularly those caused by Gram-negative drug-resistant bacteria, including Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae and Burkholderia… read more here.
Keywords: treatment antibiotic; pulmonary infections; antibiotic resistant; advancing bacteriophages ... See more keywords
Gram-negative pulmonary infections – advances in epidemiology and diagnosis
Sign Up to like & getrecommendations! Published in 2023 at "Current Opinion in Pulmonary Medicine"
DOI: 10.1097/mcp.0000000000000957
Abstract: Purpose of review Pulmonary infections due to Gram-negative organisms are increasing worldwide and traditional assumptions that these are limited to hospital and ventilator-acquired pneumonia are rapidly falling away. Accordingly, empiric antibiotic guidelines have to follow… read more here.
Keywords: infections advances; negative pulmonary; pulmonary infections; epidemiology ... See more keywords
Pulmonary co‐infections by Pneumocystis jirovecii and Aspergillus fumigatus in non‐HIV patients: A report of two cases and literature review
Sign Up to like & getrecommendations! Published in 2017 at "Mycoses"
DOI: 10.1111/myc.12642
Abstract: Pneumocystis jirovecii is the causative agent of Pneumocystis pneumonia (PcP), a common and often life‐threatening opportunistic infection in HIV‐infected patients. However, non‐HIV, immunocompromised patients are at risk of PcP as well, whereas the mortality appears… read more here.
Keywords: non hiv; hiv patients; pulmonary infections; pneumocystis jirovecii ... See more keywords
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations
Sign Up to like & getrecommendations! Published in 2022 at "European Respiratory Review"
DOI: 10.1183/16000617.0121-2022
Abstract: Lower respiratory tract infections lead to significant morbidity and mortality. They are increasingly caused by multidrug-resistant pathogens, notably in individuals with cystic fibrosis, hospital-acquired pneumonia and lung transplantation. The use of bacteriophages (phages) to treat… read more here.
Keywords: phage therapy; clinical experiences; therapy pulmonary; therapy ... See more keywords
Analysis of bacterial spectrum, activin A, and CD64 in chronic obstructive pulmonary disease patients complicated with pulmonary infections
Sign Up to like & getrecommendations! Published in 2022 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v10.i8.2382
Abstract: BACKGROUND Pulmonary infections often lead to poor prognoses in patients with chronic obstructive pulmonary disease (COPD). Activin A and CD64 play crucial pathological roles in the development of COPD. AIM To explore the bacterial spectrum… read more here.
Keywords: pulmonary infection; group; activin; infection group ... See more keywords